Published in Circulation on June 05, 2013
French Observatory on the Management of Cardiogenic Shock in 2016 (FRENSHOCK) | NCT02703038
Proof-of-Concept Study of Heart Habits Application for Patients With Heart Failure | NCT03238729
ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity. Diabetes (2015) 2.67
Cardiotoxicity of anticancer treatments. Nat Rev Cardiol (2015) 2.28
Surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience. Circulation (2014) 2.10
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease. Eur Heart J (2016) 1.52
Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry. Circ Heart Fail (2016) 1.45
Use of Pulmonary Artery Catheterization in US Patients With Heart Failure, 2001-2012. JAMA Intern Med (2016) 1.42
Cardiac innervation and sudden cardiac death. Circ Res (2015) 1.29
Phosphoregulation of Cardiac Inotropy via Myosin Binding Protein-C During Increased Pacing Frequency or β1-Adrenergic Stimulation. Circ Heart Fail (2015) 1.20
Understanding the epidemic of heart failure: past, present, and future. Curr Heart Fail Rep (2014) 1.12
Brazilian recommendations of mechanical ventilation 2013. Part 2. J Bras Pneumol (2014) 0.99
Vulnerable COPD patients with comorbidities: the role of roflumilast. Ther Clin Risk Manag (2014) 0.98
Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction. Circulation (2016) 0.96
Recovery of myofilament function through reactivation of glycogen synthase kinase 3β (GSK-3β): mechanism for cardiac resynchronization therapy. J Interv Card Electrophysiol (2014) 0.96
Diastolic dysfunction in the diabetic continuum: association with insulin resistance, metabolic syndrome and type 2 diabetes. Cardiovasc Diabetol (2015) 0.93
Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment Failure. Hypertension (2015) 0.92
Elevated pulmonary artery systolic pressure predicts heart failure admissions in African Americans: Jackson Heart Study. Circ Heart Fail (2014) 0.91
Low Intensity Physical Exercise Attenuates Cardiac Remodeling and Myocardial Oxidative Stress and Dysfunction in Diabetic Rats. J Diabetes Res (2015) 0.89
Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. J Card Fail (2014) 0.89
Diagnosis and treatment of sleep disordered breathing in hospitalized cardiac patients: a reduction in 30-day hospital readmission rates. J Clin Sleep Med (2014) 0.88
The Food and Drug Administration and pragmatic clinical trials of marketed medical products. Clin Trials (2015) 0.86
Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure. ESC Heart Fail (2016) 0.86
Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement. Int J Cardiol (2016) 0.85
Residential Proximity to Major Roadways Is Not Associated with Cardiac Function in African Americans: Results from the Jackson Heart Study. Int J Environ Res Public Health (2016) 0.85
Brazilian recommendations of mechanical ventilation 2013. Part 2. Rev Bras Ter Intensiva (2014) 0.85
Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation (2016) 0.84
Amino acids and derivatives, a new treatment of chronic heart failure? Heart Fail Rev (2015) 0.83
Epidemiology of heart failure with preserved ejection fraction. Heart Fail Clin (2014) 0.83
Predicting mortality in patients with acute heart failure: Role of risk scores. World J Cardiol (2015) 0.83
Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis. Heart Vessels (2016) 0.82
44-h ambulatory blood pressure monitoring: revealing the true burden of hypertension in pediatric hemodialysis patients. Pediatr Nephrol (2014) 0.82
Mechanical dyssynchrony precedes QRS widening in ATP-sensitive K⁺ channel-deficient dilated cardiomyopathy. J Am Heart Assoc (2013) 0.82
Dynamic Changes in High-Sensitivity Cardiac Troponin I Are Associated with Dynamic Changes in Sum Absolute QRST Integral on Surface Electrocardiogram in Acute Decompensated Heart Failure. Ann Noninvasive Electrocardiol (2016) 0.81
MicroRNA and Heart Failure. Int J Mol Sci (2016) 0.81
Rad GTPase deletion increases L-type calcium channel current leading to increased cardiac contraction. J Am Heart Assoc (2013) 0.81
Assessing the Viability of Social Media for Disseminating Evidence-Based Nutrition Practice Guideline Through Content Analysis of Twitter Messages and Health Professional Interviews: An Observational Study. J Med Internet Res (2016) 0.81
Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis. Heart Fail Rev (2015) 0.81
Targeting heart failure with preserved ejection fraction: current status and future prospects. Vasc Health Risk Manag (2016) 0.80
Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study. Clin Exp Nephrol (2015) 0.80
Effects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials. BMC Med (2015) 0.80
Use of renin-angiotensin inhibitors in people with renal artery stenosis. Clin J Am Soc Nephrol (2014) 0.80
Feasibility and Efficacy of a Self-Management Intervention for Insomnia in Stable Heart Failure. J Clin Sleep Med (2015) 0.80
Beneficial Effects of Physical Exercise on Functional Capacity and Skeletal Muscle Oxidative Stress in Rats with Aortic Stenosis-Induced Heart Failure. Oxid Med Cell Longev (2016) 0.79
Gene-environment interaction between SCN5A-1103Y and hypokalemia influences QT interval prolongation in African Americans: the Jackson Heart Study. Am Heart J (2013) 0.79
REVIVE Trial: Retrograde Delivery of Autologous Bone Marrow in Patients With Heart Failure. Stem Cells Transl Med (2015) 0.79
Variability of biomarkers in patients with chronic heart failure and healthy controls. Eur J Heart Fail (2016) 0.79
Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes. Circ Heart Fail (2016) 0.78
Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort. J Am Heart Assoc (2016) 0.78
Emerging Novel Therapies for Heart Failure. Clin Med Insights Cardiol (2015) 0.78
Hypertonic saline solution reduces the oxidative stress responses in traumatic brain injury patients. J Res Med Sci (2014) 0.78
Connective tissue growth factor (CTGF/CCN2): diagnostic and prognostic value in acute heart failure. Clin Res Cardiol (2013) 0.78
Medication Adherence Based on Part D Claims for Patients With Heart Failure After Hospitalization (from the Atherosclerosis Risk in Communities Study). Am J Cardiol (2015) 0.78
Heart failure in nursing home residents; a cross-sectional study to determine the prevalence and clinical characteristics. BMC Geriatr (2015) 0.78
Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions. Curr Heart Fail Rep (2017) 0.78
Patterns of scheduled follow-up appointments following hospitalization for heart failure: insights from an urban medical center in the United States. Clin Interv Aging (2016) 0.77
Contemporary insights and novel treatment approaches to central sleep apnea syndrome in heart failure. Curr Treat Options Cardiovasc Med (2014) 0.77
Peritoneal dialysis in patients with refractory congestive heart failure: a systematic review. Cardiorenal Med (2015) 0.77
Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure. Circ Res (2016) 0.77
Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol (2016) 0.77
Heart failure: advanced development in genetics and epigenetics. Biomed Res Int (2015) 0.77
Acute effects of low-level laser therapy irradiation on blood lactate and muscle fatigue perception in hospitalized patients with heart failure-a pilot study. Lasers Med Sci (2016) 0.77
Reparative resynchronization in ischemic heart failure: an emerging strategy. Expert Opin Biol Ther (2014) 0.76
From Bench to Bedside: New Approaches to Therapeutic Discovery for Heart Failure. Heart Lung Circ (2016) 0.76
A cohort study: temporal trends in prevalence of antecedents, comorbidities and mortality in Aboriginal and non-Aboriginal Australians with first heart failure hospitalization, 2000-2009. Int J Equity Health (2015) 0.76
Cardiac contractility modulation: a novel approach for the treatment of heart failure. Heart Fail Rev (2016) 0.76
Combined post- and pre-capillary pulmonary hypertension in heart failure with preserved ejection fraction. Heart Fail Rev (2016) 0.76
Dietary vitamin D and risk of heart failure in the Physicians' Health Study. Clin Nutr (2015) 0.75
MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis. Heart Fail Rev (2016) 0.75
Cardiac Cachexia: Perspectives for Prevention and Treatment. Arq Bras Cardiol (2016) 0.75
Prognosis of Low Normal Left Ventricular Ejection Fraction in an Asymptomatic Population-Based Adult Cohort: The Multiethnic Study of Atherosclerosis. J Card Fail (2016) 0.75
The cardiac enigma: current conundrums in heart failure research. F1000Res (2016) 0.75
Weight Loss in Obese Patients With Heart Failure. J Am Heart Assoc (2016) 0.75
Usefulness of Palliative Care to Complement the Management of Patients on Left Ventricular Assist Devices. Am J Cardiol (2016) 0.75
Guideline Recommended Medical Therapy for Cardiovascular Diseases in the Obese: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program. J Am Heart Assoc (2016) 0.75
Nutritional Deficiency in Patients with Heart Failure. Nutrients (2016) 0.75
Gradual Increases in Scheduled and Actual Early Follow-Up After Heart Failure Hospitalization: Two Steps Forward or One Step Forward? Circ Heart Fail (2016) 0.75
GDF 15 - A Novel Biomarker in the Offing for Heart Failure. Curr Cardiol Rev (2016) 0.75
Pharmacotherapy: Current role of β-blockers after MI in patients without HF. Nat Rev Cardiol (2016) 0.75
Mortality Among Patients Hospitalized With Heart Failure and Diabetes Mellitus: Results From the National Inpatient Sample 2000 to 2010. Circ Heart Fail (2016) 0.75
Development of a multiplex and cost-effective genotype test toward more personalized medicine for the antiplatelet drug clopidogrel. Int J Mol Sci (2014) 0.75
Protocol-Driven Allied Health Post-Discharge Transition Clinic to Reduce Hospital Readmissions in Heart Failure. J Am Heart Assoc (2015) 0.75
Cardiac resynchronization therapy and QRS duration: systematic review, meta-analysis, and meta-regression. J Korean Med Sci (2014) 0.75
Advances in the management of heart failure: the role of ivabradine. Vasc Health Risk Manag (2016) 0.75
Ventricular Assist Device Implantation Configurations Impact Overall Mechanical Circulatory Support System Thrombogenic Potential. ASAIO J (2016) 0.75
ACE2/Ang 1-7 axis: A critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity. Adipocyte (2016) 0.75
Experimental Heart Failure Models and Their Pathophysiological Characterization. Biomed Res Int (2016) 0.75
Circulating multimarker profile of patients with symptomatic heart failure supports enhanced fibrotic degradation and decreased angiogenesis. Biomarkers (2015) 0.75
Pedal Edema as an Indicator of Early Heart Failure in the Community: Prevalence and Associations With Cardiac Structure/Function and Natriuretic Peptides (MESA [Multiethnic Study of Atherosclerosis]). Circ Heart Fail (2016) 0.75
Impact of gait speed and instrumental activities of daily living on all-cause mortality in adults ≥65 years with heart failure. Am J Cardiol (2015) 0.75
Case 6/2014--A case of a 61-year-old woman with diastolic heart failure. Arq Bras Cardiol (2014) 0.75
Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors. Medicine (Baltimore) (2015) 0.75
Action potential-evoked calcium release is impaired in single skeletal muscle fibers from heart failure patients. PLoS One (2014) 0.75
Trimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction. BMC Cardiovasc Disord (2016) 0.75
Roles of SIRT3 in heart failure: from bench to bedside. J Zhejiang Univ Sci B (2016) 0.75
Continuity means "preserving a consistent whole"-A grounded theory study. Int J Qual Stud Health Well-being (2015) 0.75
Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies. World J Cardiol (2014) 0.75
In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial. JACC Heart Fail (2016) 0.75
Diagnostic accuracy of standard axial 64-slice chest CT compared to cardiac MRI for the detection of cardiomyopathies. Br J Radiol (2015) 0.75
Variation in Hospital Use and Outcomes Associated With Pulmonary Artery Catheterization in Heart Failure in the United States. Circ Heart Fail (2016) 0.75
Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design. Clin Cardiol (2015) 0.75
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med (2010) 14.43
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature (2011) 13.53
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med (2005) 12.46
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med (2003) 10.57
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet (2003) 9.98
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med (2012) 9.46
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med (2013) 9.44
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med (2004) 9.13
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet (2009) 8.54
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med (2012) 8.28
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet (2003) 8.12
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med (2012) 7.93
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis. N Engl J Med (2007) 7.86
Rosuvastatin in older patients with systolic heart failure. N Engl J Med (2007) 7.55
Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med (2006) 7.54
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med (2005) 6.86
HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail (2010) 6.37